Roche Holding Aktiengesellschaft operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Roche Holding Aktiengesellschaft with three other
companies in this sector in the United States:
Merck & Co. , Inc.
sales of $39.81 billion
of which 88%
was Merck Pharmaceutical),
of which 66%
was innovative medicines), and
of which 55%
was Operating Segment-Global Innovative Phar).
Roche Holding Aktiengesellschaft reported sales of $51.16 billion
December of 2016.
increase of 2.4%
versus 2015, when the company's sales were $49.93 billion.
Despite this increase, sales are still
below the level achieved in 2014, when Roche Holding Aktiengesellschaft
reported sales of $51.68 billion.
The sales level in 2016 was fairly close to the level five years ago: in 2011, Roche Holding Aktiengesellschaft had sales
of $48.40 billion.
Sales of Diagnostics saw an increase
3.5% in 2016, from
$11.22 billion to $11.60 billion.